Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 6, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • A new strategy for Covid: Targeting TMPRSS2 and ACE2 (Androgenic Regulations)

Covance Life Science Manager | Analytical Development

Stem cell-derived human lung organoid model- the next chapter in Viral Disease Research?

A new strategy for Covid: Targeting TMPRSS2 and ACE2 (Androgenic Regulations)
  • BiotechToday
  • World

A new strategy for Covid: Targeting TMPRSS2 and ACE2 (Androgenic Regulations)

bioxone October 20, 2020October 20, 2020

Anwesha Chatterjee, Amity University Kolkata

The novel Corona Virus (SARS-CoV-2) infection which is responsible for the COVID-19 pandemic is expecting an adverse effect on the progression of multiple cancers, i.e. prostate cancer, due to the transpiring cytokine storm associated with oncogenic signalling. Cancer progression can be prevented at an early stage by blocking SARS-COV-2 infection through potential therapies of host cell factors and their regulations. Host cell infections by SARS-COV-2 need priming of Viral spike S  protein by serine protease TMPRSS2 which is encrypted by Androgen Response Gene and expressed in prostate cancer patients; the host cell also needed binding of the same protein to the ACE2 receptor.

Epidemiologically, the data showed increased severity and mortality in SARS-CoV-2 infected men, which suggested primary infection sites and other possible roles for Androgen in the transcriptional activation of ACE2 and TMPRSS2 receptors in mice tissue and human prostate and lung cell lines. Also, the endogenous interaction between the TMPRSS2 and ACE2 has been demonstrated in human cells, and ACE2 is substantiated as a TMPRSS2 substrate. Camostat ~ a TMPRSS2 inhibitor blocked the cleft of the SARS-COV-2 surface without obstructing ACE2 – TMPRSS2 interaction, in an overexpressed model of prostate and lung cells.

Altogether, the preclinical results showed a very strong ground of justification for clinical evaluation of androgen – deprivation therapy, TMPRSS2 inhibitors, and androgen receptor antagonist; or in amalgamation with antiviral drugs as clinically possible to prevent progression of Pneumonia and hyper inflammation response-driven to COVID-19 patients.

Also read: Covid Update: Moderna Vaccine on the Horizon!

Reference – https://www.biorxiv.org/content/10.1101/2020.10.16.342782v1

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged ACE2 Androgen Response Gene Camostat COVID-19 cytokine storm deprivation therapy prostate cancer SARS-CoV-2 TMPRSS2

One thought on “A new strategy for Covid: Targeting TMPRSS2 and ACE2 (Androgenic Regulations)”

  1. Tahani parinaz says:
    October 21, 2020 at 4:17 am

    MashaAllah

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Stem cell-derived human lung organoid model- the next chapter in Viral Disease Research?

bioxone October 20, 2020

Sampriti Roy, Asutosh College, University of Calcutta SARS-CoV-2, the talk of the town (read “world”), still lacks information related to its origin and exact mechanism.  The virus, found to cause DAD (diffuse alveolar damage), leads to respiratory failure which appears to be the common mechanism of death in patients with severe COVID-19 infection. However, with […]

lung organoid

Related Post

  • BiotechToday
  • World

Can Lupus & rheumatoid arthritis patients safely get Covid jabs?

BioTech Today August 6, 2021August 5, 2021

Soumya Shraddhya Paul, Amity University, Noida Rheumatoid arthritis patients may be afraid that the COVID-19 vaccination will have negative side effects, aggravating their disease. Some people have even said that they do not believe it is safe for them to get the vaccine. That, however, is not the case. According to specialists, the chances of […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

VEGAN MILK vs ANIMAL DAIRY PRODUCTS

bioxone June 3, 2021June 2, 2021

Camelia Bhattacharyya, Amity University Kolkata There has always been a lot of debates surrounding vegan food. While some vegans at times drink milk, others show complete avoidance towards any kind of milk products including dairy as well. This might at times raise questions on the diet chart followed by the vegans. It is surely good […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

You could be at greater COVID risk if you have Neanderthal genes

bioxone October 5, 2020October 5, 2020

-Anuska Sen, Team bioXone Neanderthals also called Homo neanderthalensis or Homo sapiens neanderthalensis are an extinct group of early humans, which was existent almost 40,000 years back. These individuals lived in Eurasia until they became extinct and there are pieces of evidence that till date a certain percentage of Europeans and South Asians are genetically linked to these Neanderthals. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy